期刊文献+

次要ABO血型不合的“微移植”后过路淋巴细胞综合征1例报道并文献复习 被引量:4

下载PDF
导出
摘要 “微移植”是Guo等在国际上提出的急性白血病治疗新技术,即在适度强化疗基础上,联合重组人粒细胞集落刺激因子(G—CSF)动员的人类白细胞抗原(HLA)不相合健康亲缘供者外周血干细胞输注治疗急性白血病,
出处 《浙江医学》 CAS 2015年第18期1554-1556,共3页 Zhejiang Medical Journal
  • 相关文献

参考文献22

  • 1Guo M, Hu K X, Liu G X, et al.HLA-mis-matched stem-cell microtransplantationas postremission therapy for acutemyeloid leukemia: long-term follow-up[J]. J Clin Oncol,2012,30(33):4084-4090.
  • 2Smith E P. Hematologic disorders aftersolid organ transplantation [J], Hematol-ogy Am Soc Hematol Educ Program,2010,2010:281-286.
  • 3Seebach J D, Stussi G, Passweg J R, etal. ABO blood group barrier in allogeneicbone marrow transplantation revisited [J].Biol Blood Marrow Transplant,2005,11(12):1006-1013.
  • 4Karanth P, Bircha丨I J, Day S,et al. Immunehemolysis resulting from passenger lym-phocyte syndrome derived anti-rh (D)reactivity after kidney transplantation: acase report and literature review [J],Transplantation,2014,97(9):e54-55.
  • 5刘代红.造血干细胞移植后溶血和纯红细胞再生障碍性贫血[J].临床血液学杂志,2014,27(A02):192-194. 被引量:3
  • 6Watz E, Remberger M, Ringden O,et al.Analysis of donor and recipient ABO in-compatibility and antibody-associatedcomplications after allogeneic stem celltransplantation with reduced-intensityconditioning[J].Biol Blood Marrow Trans-plant,2014,20(2):264-271.
  • 7Helbig G, Stella-Holowiecka B, Wojnar J,et al. Pure red-cell aplasia following ma-jor and bi-directional ABO-incompatibleallogeneic stem-cell transplantation: re-covery of donor-derived erythropoiesisafter long-term treatment using differenttherapeutic strategies [J].Ann Hematol,2007,86(9):677-683.
  • 8Erker C G, Steins M B, Fischer R J, et al.The influence of blood group differencesin allogeneic hematopoietic peripheralblood progenitor cell transplantation [J],Transfusion,2005,45(8): 1382-1390.
  • 9Audet M, Panaro F, Piardi T, et al. Pas-senger lymphocyte syndrome and livertransplantation [J]. Clin Dev Immunol,2008, 2008:715769.
  • 10Nadarajah L, Ashman N, ThuraisinghamR, et al. Literature review of passengerlymphocyte syndrome following renaltransplantation and two case reports[J].Am J Transplant,2013,13(6): 1594-1600.

二级参考文献13

  • 1黄晓军,刘代红,许兰平,韩伟,江倩,陈育红,张耀臣,刘开彦,鲍立,陆道培.主要ABO血型不合异基因造血干细胞移植后纯红细胞再生障碍[J].中华血液学杂志,2005,26(9):548-550. 被引量:26
  • 2Makoto Hirokawa,Takahiro Fukuda,Kazuteru Ohashi,Michihiro Hidaka,Tatsuo Ichinohe,Koji Iwato,Heiwa Kanamori,Makoto Murata,Toru Sakura,Masahiro Imamura,Soichi Adachi,Ritsuro Suzuki,Yasuo Morishima,Hisashi Sakamaki.Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors[J].Biology of Blood and Marrow Transplantation.2013(7)
  • 3Fleur M. Aung,Benjamin Lichtiger,Roland Bassett,Ping Liu,Amin Alousi,Qaiser Bashier,Stefan O. Ciurea,Marcos J. Lima,Chitra Hosing,Partow Kebriaei,Yago Nieto,Betul Oran,Simrit Parmar,Muzaffar Qazilbash,Nina Shah,Issa Khouri,Richard E. Champlin,Uday Popat.Incidence and natural history of pure red cell aplasia in major ABO ‐mismatched haematopoietic cell transplantation[J].Br J Haematol.2013(6)
  • 4Panagiotis Tsirigotis,Konstantinos Girkas,Christina Economopoulou,Anthoula Bouchla,Nikolaos Papanicolaou,Panagiota Economopoulou,Sotirios Papageorgiou,Vassiliki Pappa,John Dervenoulas,C. Costa,G. Forrest,A. G. Freifeld,N. Leveque.Pure Red Cell Aplasia due to B19 Parvovirus Infection after Autologous Stem Cell Transplantation[J].Case Reports in Transplantation.2011
  • 5E.D.Lagadinou,M.Marangos,M.Liga,G.Panos,E.Tzouvara,E.Dimitroulia,M.Tiniakou,A.Tsakris,N.Zoumbos,A.Spyridonidis.Human herpesvirus 6‐related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet[J].Transplant Infectious Disease.2010(5)
  • 6DaphneDahl,AndreasHahn,ChristianKoenecke,Hans‐GertHeuft,ElkeDammann,MichaelStadler,StefanieBuchholz,JürgenKrauter,MatthiasEder,Karl‐WalterSykora,ChristophKlein,ArnoldGanser,MartinSauer.TRANSPLANTATION AND CELLULAR ENGINEERING: Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk[J].Transfusion.2010(3)
  • 7J?rg D. Seebach,Georg Stussi,Jakob R. Passweg,Fausto R. Loberiza,James L. Gajewski,Armand Keating,Martin Goerner,Philip A. Rowlings,Pierre Tiberghien,Gerald J. Elfenbein,Robert Peter Gale,Jon J. van Rood,Vijay Reddy,Eliane Gluckman,Brian J. Bolwell,Thomas R. Klumpp,Mary M. Horowitz,Olle Ringdén,A. John Barrett.ABO Blood Group Barrier in Allogeneic Bone Marrow Transplantation Revisited[J].Biology of Blood and Marrow Transplantation.2005(12)
  • 8NinaWorel,Hildegard T.Greinix,FelixKeil,MargitMitterbauer,KlausLechner,GottfriedFischer,WolfgangMayr,PaulH?cker,PeterKalhs.Severe immune hemolysis after minor ABO‐mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning[J].Transfusion.2002(10)
  • 9P.Bavaro,G.Di Girolamo,P.Olioso,G.Papalinetti,A.Iacone,P.Accorsi,P.Di Bartolomeo.Donor lymphocyte infusion as therapy for pure red cell aplasia following bone marrow transplantation[J].British Journal of Haematology.2001(4)
  • 10Corti P,Bonanomi S,Vallinoto C,Balduzzi A,Uderzo C,Cazzaniga G,Gaipa G,Dassi M,Perseghin P,Rovelli A.Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic stem cell transplantation[].Acta Haematologica.2002

共引文献2

同被引文献16

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部